CTLA4 and myocarditis: In a case report, abatacept, a cytotoxic T-lymphocyte-associated antigen 4 [CTLA-4] agonist, showed the capability to resolve a severe case of glucocorticoid-refractory myocarditis that was induced by the immune checkpoint inhibitor nivolumab [54].